The More Persistent and Severe the Sleep Disorder, the Greater the Cancer Risk
Sleep disorders have been linked to cancer incidence. A new study investigates how the duration and severity of the sleep disturbance impact that risk.
Sleep disorders have been linked to cancer incidence. A new study investigates how the duration and severity of the sleep disturbance impact that risk.
As Incannex advances IHL-42X, a cannabinoid combination product, into phase 2/3 clinical trials for treating OSA, CEO Joel Latham praises early trial outcomes, signaling strong potential for the drug's marketability.
The company’s CARE oral devices for sleep apnea are now eligible for Medicare reimbursement, broadening accessible treatment alternatives for beneficiaries.
A study investigating sleep apnea prevalence in 2- to 6-year-olds uncovers significant research roadblocks.
Read MoreFor every unit of BMI increase over 32, the odds of successful treatment decrease by about 17%, a new study finds.
Read MoreThe AI-powered solution demonstrated 95.8% accuracy for defining severe obstructive sleep apnea.
Read MoreThe risk of increased health care utilization among children with a chronic medical condition is higher for those who also have a sleep disorder.
Read MoreIn its fourth-quarter and full-year 2023 highlights, Vivos Therapeutics reported positive business momentum following receiving US Food and Drug Administration clearance for its oral appliances to treat severe obstructive sleep apnea last November.
Read MoreWhy cosmetic dentist Rhonda Kalasho screens patients for sleep apnea at TruGLO Modern Dental.
Read MoreThe company reported a 43% increase in annual revenue for 2023, driven in part by greater adoption of its oral appliance therapy for obstructive sleep apnea.
Read MoreThe partnership seeks improve patient access to new sleep apnea treatments by streamlining authorization pathways and advocating for broader access to neurostimulator therapies.
Read MoreLivaNova announced that its OSPREY clinical study assessing the aura6000 hypoglossal nerve stimulation system in patients with obstructive sleep apnea achieved a positive predictive outcome and will conclude enrollment earlier than anticipated.
Read MoreNyxoah announced 12-month results from its DREAM US pivotal study, designed to support the marketing authorization of the Genio hypoglossal nerve stimulation system for obstructive sleep apnea in the United States.
Read MoreFrom microphones to piezoelectric and cannulas, sleep techs and other experts explain how they work and the pros and cons of each technology.
Read MoreSleep is as essential to our health as food and water. For World Sleep Day, experts to tell us more about this essential part of our lives.
Read MoreAdults with insomnia symptoms used the CBT-I program over 18 months and reported significant and sustained improvements.
Read MoreBlueSleep, a specialty care digital platform focused on snoring and sleep apnea, is partnering with Shapely, a virtual weight-loss and wellness clinical pathway, to expand patient access to the platforms.
Read MoreSleep Specialists LLC and ISD Health Solutions have partnered to bring Zzoma to patients with mild to moderate positional obstructive sleep apnea in the Caribbean.
Read More